Publicaciones en colaboración con investigadores/as de Uppsala University (10)

2015

  1. Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: Challenges and opportunities

    Clinical Pharmacology and Therapeutics, Vol. 97, Núm. 1, pp. 37-54

  2. Pharmacometrics Markup Language (PharmML): Opening new perspectives for model exchange in drug development

    CPT: Pharmacometrics and Systems Pharmacology, Vol. 4, Núm. 6, pp. 316-319

2014

  1. A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysis

    CPT: Pharmacometrics and Systems Pharmacology, Vol. 3, Núm. 5

2011

  1. Predictive ability of a semi-mechanistic model for neutropenia in the development of novel anti-cancer agents: Two case studies

    Investigational New Drugs, Vol. 29, Núm. 5, pp. 984-995

2010

  1. Incorporating physiological and biochemical mechanisms into pharmacokinetic-pharmacodynamic models: A conceptual framework

    Basic and Clinical Pharmacology and Toxicology

  2. Modelling the genesis and treatment of cancer: The potential role of physiologically based pharmacodynamics

    European Journal of Cancer, Vol. 46, Núm. 1, pp. 21-32

2009

  1. Modelling overdispersion and markovian features in count data

    Journal of Pharmacokinetics and Pharmacodynamics, Vol. 36, Núm. 5, pp. 461-477

  2. Performance in population models for count data, part I: Maximum likelihood approximations

    Journal of Pharmacokinetics and Pharmacodynamics, Vol. 36, Núm. 4, pp. 353-366

2004

  1. Modelling and simulation in the development and use of anti-cancer agents: An underused tool?

    Journal of Pharmacokinetics and Pharmacodynamics

1998

  1. Population pharmacodynamic modeling of levodopa in patients with Parkinson's disease receiving entacapone

    Clinical Pharmacology and Therapeutics, Vol. 64, Núm. 1, pp. 106-116